Ailin Zhang

Ailin Zhang

Auto-generated profile, based on publicly available information

Ailin Zhang

Pharmaceutical College Tianjin Medical University Tianjin China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VMValerie Morris
Valerie Morris
AZAilin Zhang
Ailin Zhang
TYTaimei Yang
Taimei Yang
DSDerek L. Stirewalt
Derek L. Stirewalt
RRRanjani Ramamurthy
Ranjani Ramamurthy
VOVivian G. Oehler
Vivian G. Oehler
In acute myeloid leukemia (AML) and blast crisis (BC) chronic myeloid leukemia (CML) normal differentiation is impaired. Differentiation of immature stem/progenitor cells is critical for normal blood cell function. MicroRNAs (miRNAs or miRs) are small non-coding RNAs that interfere with gene expression by degrading messenger RNAs (mRNAs) or blocking protein translation. Aberrant miRNA expression is a feature of leukemia and miRNAs also play a significant role in normal hematopoiesis and differentiation. We have identified miRNAs differentially expressed in AML and BC CML and identified a new role for miR-150 in myeloid differentiation. Expression of miR-150 is low or absent in BC CML and AML patient samples and cell lines. We have found that expression of miR-150 in AML cell lines, CD34+ progenitor cells from healthy individuals, and primary BC CML and AML patient samples at levels similar to miR-150 expression in normal bone marrow promotes myeloid differentiation of these cells. MYB is a direct target of miR-150, and we have identified that the observed phenotype is partially mediated by MYB. In AML cell lines, differentiation of miR-150 expressing cells occurs independently of retinoic acid receptor α (RARA) signaling. High-throughput gene expression profiling (GEP) studies of the AML cell lines HL60, PL21, and THP-1 suggest that activation of CEPBA, CEBPE, and cytokines associated with myeloid differentiation in miR-150 expressing cells as compared to control cells contributes to myeloid differentiation. These data suggest that miR-150 promotes myeloid differentiation, a previously uncharacterized role for this miRNA, and that absent or low miR-150 expression contributes to blocked myeloid differentiation in acute leukemia cells.

14 November 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YSYuxuan Sun
Yuxuan Sun
AZAilin Zhang
Ailin Zhang
MZMeiling Zuo
Meiling Zuo
JCJingtao Chen
Jingtao Chen
LZLiqin Zhu
Liqin Zhu

1 April 2016 in European Urology
Verified
Journal Article
Closed access
EMElahe A. Mostaghel
Elahe A. Mostaghel
AZAilin Zhang
Ailin Zhang
SPStephen R. Plymate
Stephen R. Plymate

16 October 2008 in Urological Research
Verified
Journal Article
Closed access
PDF file
SMSusan Ruth Marengo
Susan Ruth Marengo
AZAilin Zhang
Ailin Zhang
ETEdward J. Traverso
Edward J. Traverso

1 April 2007 in Journal of Urology
Verified
Journal Article
Closed access
SMSusan R. Marengo
Susan R. Marengo
AZAilin Zhang
Ailin Zhang

15 April 2012 in Cancer Research
Verified
Journal Article
Closed access
VMValerie A. Morris
Valerie A. Morris
AZAilin Zhang
Ailin Zhang
VOVivian G. Oehler
Vivian G. Oehler
Blocked myeloid differentiation is a major feature of chronic myeloid leukemia (CML) disease progression and acute myeloid leukemia (AML). Normal myeloid differentiation is a tightly controlled process involving the coordinated action of specific transcription factors, which are dysregulated by chromosomal translocations, DNA mutations, epigenetic changes, and aberrant gene and microRNA (miRNA) expression in leukemias. Previously, we identified decreased miR-150 expression in CML and AML cell lines and primary cells when compared to normal bone marrow, and determined miR-150 expression is decreased in CML by the Bcr-Abl fusion protein. Furthermore, lentiviral expression of miR-150 in AML cell lines and primary CML patient samples induced myeloid differentiation as detected by CD11b expression, morphologic differentiation, and colony forming ability in methylcellulose, both in the absence and presence of the differentiating agents. In this study, we elucidated the targets responsible for miR-150 induced differentiation. Expression of the validated miR-150 target MYB, a transcription factor involved in blocking differentiation in progenitor cells, was only decreased in miR-150 expressing cells in the presence of differentiating agent all-trans retinoic acid (ATRA). Furthermore, lentiviral overexpression of MYB lacking miR-150 binding sites in the 3′-UTR partially decreased the CD11b expression in the presence and absence of ATRA in both control and miR-150 expressing HL60 cells. These results suggest additional miR-150 targets are involved in differentiation besides MYB. To identify additional miRNA-150 targets, we profiled changes in mRNAs associated with the RNA-induced silencing complex (RISC) using RNA-immunoprecipitation of Ago2 followed by microarray gene expression profiling in miR-150 versus control HL60 cells. Furthermore, although almost all functional investigations have focused on the mature strand, we have found that miR-150 and its partner star strand miR-150* are expressed at almost equal levels in normal myeloid hematopoietic cells, and are investigating the individual contributions of their separate targets in induction of differentiation. In conclusion, miR-150 expression promotes myeloid differentiation through targeting transcription factor MYB and additional targets, while downregulation of miR-150 in myeloid leukemias contributes to the block in differentiation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 146. doi:1538-7445.AM2012-146